mianserin has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xing, S | 1 |
| Kim, S | 1 |
| Schumock, GT | 1 |
| Touchette, DR | 1 |
| Calip, GS | 1 |
| Leow, AD | 1 |
| Lee, TA | 1 |
| Deuschle, M | 1 |
| Angermeier, T | 1 |
| Westphal, S | 1 |
| Lederbogen, F | 1 |
| Gilles, M | 1 |
| Frankhauser, P | 1 |
| Schilling, C | 1 |
| Onken, V | 1 |
| Weber-Hamann, B | 1 |
| Kopf, D | 1 |
| Wolter-Henseler, D | 1 |
1 trial available for mianserin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Secti | 2010 |
2 other studies available for mianserin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antip | 2018 |
[Blood glucose dysregulation with mianserin].
Topics: Aged; Antidepressive Agents, Second-Generation; Blood Glucose; Depressive Disorder; Diabetes Mellitu | 1996 |